
Organization · Venture Capital
AllosteRx Capital Management (Canada) Inc.
AllosteRx Capital Management (Canada) Inc. is a venture capital firm specializing in early-stage biotechnology investments in under-ventured regions of the United States and Canada.
Overview
What AllosteRx Capital Management (Canada) Inc. does
What AllosteRx Capital Management (Canada) Inc. is
AllosteRx Capital Management (Canada) Inc. is a venture capital firm specializing in early-stage biotechnology investments in under-ventured regions of the United States and Canada.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find AllosteRx Capital Management (Canada) Inc. elsewhere
Open the official website or a supported primary organization account.
Capability profile
AllosteRx Capital Management (Canada) Inc. as a funder
Investment thesis
AllosteRx Capital focuses on backing early biotechnology innovation from under-ventured regions and institutions in the United States and Canada.
Focus narrative
AllosteRx Capital invests primarily in early-stage biotechnology companies, particularly those emerging from under-ventured areas. The firm is committed to nurturing innovation in the biotechnology sector, focusing on therapeutics, advanced therapies, medical devices, and diagnostics.
Value beyond capital
AllosteRx Capital adds value to its portfolio companies by leveraging the extensive experience of its team in building and financing life-sciences ventures. The firm provides not only capital but also operational support to help companies navigate the complexities of bringing innovative therapies to market.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity
- Sectors
- Biotech · Medical Devices · Diagnostics
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
The current portfolio of AllosteRx Capital is not publicly disclosed, but the firm is known to support early biotechnology and advanced-therapy companies.
Connected ecosystem
Continue from AllosteRx Capital Management (Canada) Inc.
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about AllosteRx Capital Management (Canada) Inc.
Upseed classifies AllosteRx Capital Management (Canada) Inc. under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.